Lynx Therapeutics Inc
LYNX · Chemicals & Drugs · NASDAQ · in our data December 30, 1997 to January 26, 2007 (9.1 years)
The first trading day in our data for Lynx Therapeutics Inc is December 30, 1997 (its first day in our records, which may be later than its listing and is not its founding). At its peak, on March 1, 2000, the market valued it at $1.1 billion. It ended in a collapse: the last trade was $13.47, -99.0% from its split-adjusted high. The delisting record says: merged or acquired.
Share prices are adjusted for splits and other share changes, so the high and the last price compare like for like; the peak market value is as it was on the day. The return covers the trading days in our data only: it does not include what holders received, or lost, after the last trade (a merger payout, a bankruptcy), and it does not reach back before 1997. How these numbers are made · Report a data issue.
Play today's Daily DropAlso gone in 2007: Chemicals & Drugs
- MedImmune peaked at $17.7 billion
- Lyondell Chemical peaked at $12.2 billion
- Dade Behring Holdings Inc peaked at $6.2 billion
- Bausch & Lomb peaked at $4.7 billion
- Icos Corp peaked at $3.7 billion
- New River Pharma Inc peaked at $2.4 billion
